Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (48)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  2. Young Women’s Needs Regarding Sexual Preventive Behaviours and Unwanted Pregnancies

    Healthcare (Switzerland), Vol. 12, Núm. 4

2023

  1. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)

    International Journal of Cancer, Vol. 153, Núm. 5, pp. 979-993

  2. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

    Psychological Medicine

  3. Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Anales de Pediatria, Vol. 98, Núm. 3, pp. 213-227

  4. Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Atencion Primaria, Vol. 55, Núm. 6

  5. Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 111-122

  6. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental

  7. Mediterranean diet and risk of breast cancer: An umbrella review

    Clinical Nutrition, Vol. 42, Núm. 4, pp. 600-608

  8. Obstetric complications and clinical presentation in first episode of psychosis

    Acta Neuropsychiatrica

  9. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  10. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  11. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Association of time of breakfast and nighttime fasting duration with breast cancer risk in the multicase-control study in Spain

    Frontiers in Nutrition, Vol. 9

  2. Epigenetic clocks in relapse after a first episode of schizophrenia

    Schizophrenia, Vol. 8, Núm. 1

  3. Family history of first degree as a risk factor for colorectal cancer

    Gaceta Sanitaria, Vol. 36, Núm. 4, pp. 345-352

  4. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

    Schizophrenia, Vol. 8, Núm. 1

  5. Meat Intake, Cooking Methods, Doneness Preferences and Risk of Gastric Adenocarcinoma in the MCC-Spain Study

    Nutrients, Vol. 14, Núm. 22

  6. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  7. Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study

    Nefrologia, Vol. 42, Núm. 5, pp. 594-606